An issue of HCA Holdings Inc. (NYSE:HCA) bonds rose 0.8% as a percentage of their face value during trading on Thursday. The high-yield debt issue has a 4.75% coupon and is set to mature on May 1, 2023. The debt is now trading at $101.05 and was trading at $103.63 last week. Price changes in a company’s bonds in credit markets often anticipate parallel changes in its stock price.

HCA has been the subject of several recent analyst reports. Zacks Investment Research raised shares of HCA Holdings from a “hold” rating to a “buy” rating and set a $89.00 price objective for the company in a research report on Tuesday, July 26th. JPMorgan Chase & Co. cut shares of HCA Holdings from an “overweight” rating to a “neutral” rating and set a $85.00 price objective for the company. in a research report on Friday, July 29th. Mizuho reaffirmed a “buy” rating and set a $97.00 price objective (down previously from $102.00) on shares of HCA Holdings in a research report on Friday, July 29th. Citigroup Inc. cut their price objective on shares of HCA Holdings from $86.00 to $85.00 and set a “neutral” rating for the company in a research report on Friday, July 29th. Finally, Credit Suisse Group AG reaffirmed a “buy” rating and set a $87.00 price objective on shares of HCA Holdings in a research report on Friday, July 29th. Nine equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. HCA Holdings currently has a consensus rating of “Buy” and a consensus price target of $87.30.

Shares of HCA Holdings Inc. (NYSE:HCA) opened at 72.39 on Friday. The firm’s 50-day moving average is $76.75 and its 200-day moving average is $77.18. HCA Holdings Inc. has a 52-week low of $60.07 and a 52-week high of $83.69. The firm has a market cap of $27.12 billion, a P/E ratio of 11.46 and a beta of 0.79.

HCA Holdings (NYSE:HCA) last posted its earnings results on Thursday, October 27th. The company reported $1.61 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.42 by $0.19. The business earned $10.27 billion during the quarter, compared to analyst estimates of $10.41 billion. HCA Holdings had a negative return on equity of 43.65% and a net margin of 6.10%. The company’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.17 EPS. Analysts anticipate that HCA Holdings Inc. will post $6.71 earnings per share for the current year.

In other news, SVP Sandra L. Morgan sold 18,556 shares of the business’s stock in a transaction dated Tuesday, November 8th. The stock was sold at an average price of $76.84, for a total transaction of $1,425,843.04. Following the completion of the transaction, the senior vice president now owns 7,968 shares of the company’s stock, valued at $612,261.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction dated Friday, October 28th. The stock was sold at an average price of $79.41, for a total value of $170,731.50. The disclosure for this sale can be found here. Company insiders own 3.10% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of HCA. Conning Inc. raised its position in shares of HCA Holdings by 0.4% in the second quarter. Conning Inc. now owns 7,100 shares of the company’s stock valued at $547,000 after buying an additional 30 shares during the last quarter. Pitcairn Co. raised its position in shares of HCA Holdings by 0.3% in the second quarter. Pitcairn Co. now owns 10,972 shares of the company’s stock valued at $844,000 after buying an additional 31 shares during the last quarter. Boston Advisors LLC raised its position in shares of HCA Holdings by 0.5% in the third quarter. Boston Advisors LLC now owns 7,210 shares of the company’s stock valued at $545,000 after buying an additional 35 shares during the last quarter. Bristlecone Advisors LLC raised its position in shares of HCA Holdings by 0.9% in the third quarter. Bristlecone Advisors LLC now owns 5,615 shares of the company’s stock valued at $425,000 after buying an additional 50 shares during the last quarter. Finally, Northern Capital Management LLC raised its position in shares of HCA Holdings by 0.5% in the third quarter. Northern Capital Management LLC now owns 10,705 shares of the company’s stock valued at $810,000 after buying an additional 50 shares during the last quarter. 71.43% of the stock is owned by institutional investors.

HCA Holdings Company Profile

HCA Holdings, Inc is a healthcare services company. The Company’s segment is operating hospitals and related healthcare entities. The Company operates approximately 168 hospitals, consisting of 164 general, acute care hospitals; three psychiatric hospitals, and one rehabilitation hospital. In addition, the Company operates approximately 116 freestanding surgery centers.

5 Day Chart for NYSE:HCA

Receive News & Stock Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related stocks with our FREE daily email newsletter.